Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1 (Q24294403)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1	scientific article

Statements

scholarly article

0 references

Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1 (English)

0 references

Fibroblast growth factor receptor 4

1 reference

GOA release 2020-03-11

regulation of bile acid biosynthetic process

1 reference

GOA release 2020-03-11

1 reference

based on heuristic

inferred from title

author name string

Vassilis Triantis

1

0 references

Eirikur Saeland

2

0 references

Nora Bijl

3

0 references

Ronald P Oude-Elferink

4

0 references

Peter L M Jansen

5

0 references

language of work or name

0 references

publication date

August 2010

0 references

0 references

52

0 references

2

0 references

656-66

0 references

Identification of a hormonal basis for gallbladder filling.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Endocrine FGFs and Klothos: emerging concepts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Liver-specific activities of FGF19 require Klotho beta

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

BetaKlotho is required for metabolic activity of fibroblast growth factor 21

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Co-receptor requirements for fibroblast growth factor-19 signaling

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Fibroblast growth factor receptor-induced phosphorylation of STAT1 at the Golgi apparatus without translocation to the nucleus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Brefeldin A: insights into the control of membrane traffic and organelle structure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

The alpha(1,2)-mannosidase I inhibitor 1-deoxymannojirimycin potentiates the antiviral activity of carbohydrate-binding agents against wild-type and mutant HIV-1 strains containing glycan deletions in gp120.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Relevant use of Klotho in FGF19 subfamily signaling system in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

21 January 2018

Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23708

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.23708

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24294403&oldid=1623486284"